Milan J Anadkat MD

Dermatology•St. Louis, MO

Professor, Dermatology Director of Dermatology Clinical Trials, Washington University School of Medicine

Join to View Full Profile

4901 Forest Park Ave# DvSt. Louis, MO 63108
Phone+1 314-273-3376
Fax+1 888-665-8309

Summary

Dr. Milan Anadkat is a dermatologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Siteman Cancer Center. He received his medical degree from Northeast Ohio Medical University and has been in practice 16 years. He is experienced in general and complex medical dermatology, chemotherapy related skin toxicity, autoimmune bulls disease, hidradenitis, and graft-versus-host disease.

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2004 - 2007
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2001 - 2002
Northeast Ohio Medical UniversityClass of 2001

Certifications & Licensure

MO State Medical License 2002 - 2027
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Modular), Allscripts, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2012, 2014, 2016-2017

Clinical Trials

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash Start of enrollment: 2008 Apr 03
Completed
Phase 1
A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis Start of enrollment: 2020 Jun 04
COMPLETED
PHASE2
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
WITHDRAWN
PHASE2
Roles: Contact

Publications & Presentations

PubMed

Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-b...
Evangelos J Giamarellos-Bourboulis, Gregor B E Jemec, Errol P Prens, Niels C Riedemann, Isabell Otto
The British Journal of Dermatology. 2026-01-27
The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in perip...
James M Kilgour, Hal Landy, Alexa B Kimball, Barry I Resnik, Milan J Anadkat
Journal of the American Academy of Dermatology. 2026-01-01
2 citations
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.
James G Krueger, Mrinal K Sarkar, Mark G Lebwohl, Akimichi Morita, Kenneth Gordon
The Journal of Clinical Investigation. 2025-09-02

Journal Articles

Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host Disease
Karl M Saardi, Rachel K Rosenstein, Milan J Anadkat, JAMA Dermatology

Lectures

Dermatologic Findings in the Stem Cell Transplant Patient
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
Inflammatory Bowel Disease 2013
Washington University School of Medicine, Saint Louis, Missouri - 6/8/2013
Florida Society of Dermatology & Dermatologic Surgery (FSDDS) 2012 Annual Meeting
Florida Society of Dermatology & Dermatologic Surgery, Orlando, Florida - 5/25/2012

Authored Content

Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host DiseaseMay 2020

Press Mentions

Study Adds Evidence on the Link Between Leukemia Cutis and Poor Prognosis in AMLMay 6th, 2019

Professional Memberships

American Academy of Dermatology - AAD
Fellow